Novo Nordisk Balance Sheet Health
Financial Health criteria checks 4/6
Novo Nordisk has a total shareholder equity of DKK98.9B and total debt of DKK26.9B, which brings its debt-to-equity ratio to 27.2%. Its total assets and total liabilities are DKK298.9B and DKK200.0B respectively. Novo Nordisk's EBIT is DKK110.8B making its interest coverage ratio -210.3. It has cash and short-term investments of DKK9.3B.
Key information
27.2%
Debt to equity ratio
kr.26.93b
Debt
Interest coverage ratio | -210.3x |
Cash | kr.9.30b |
Equity | kr.98.91b |
Total liabilities | kr.200.01b |
Total assets | kr.298.92b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NNO2's short term assets (DKK116.4B) do not cover its short term liabilities (DKK165.6B).
Long Term Liabilities: NNO2's short term assets (DKK116.4B) exceed its long term liabilities (DKK34.4B).
Debt to Equity History and Analysis
Debt Level: NNO2's net debt to equity ratio (17.8%) is considered satisfactory.
Reducing Debt: NNO2's debt to equity ratio has increased from 9.1% to 27.2% over the past 5 years.
Debt Coverage: NNO2's debt is well covered by operating cash flow (346.9%).
Interest Coverage: NNO2 earns more interest than it pays, so coverage of interest payments is not a concern.